Latest News Read All News DCP Participation in National Academies of Science Engineering, and Medicine (NASEM) MCD Workshop: Opportunities and Challenges for the Development and Adoption of Multicancer Detection Tests – October 28-29, 2024 This hybrid NASEM MCD workshop will examine the state of the science for clinical use of multi-cancer detection (MCD) tests. The NCI Division of Cancer Prevention staff will present on Monday, October 28. View the MCD Public… October 17 | DCP News DCP Participation at Biomedical Engineering Society (BMES) Annual Meeting - October 24, 2024 The Biomedical Engineering Society (BMES) Annual Meeting will be held October 23-26, 2024, in Baltimore. “Synergizing Research and Cultural Excellence” is this year’s theme. The NCI Division of Cancer Prevention staff will… October 15 | DCP News G7 Lung Cancer Screening Seminar, TACPAD Virtual Meeting, NOFOs, and More Emergency Notice, Upcoming Events, Latest News, Notice of Funding Opportunities (NOFOs), Reminders October 1 | DCP Updates NCORP-supported Research Shows Olanzapine May Reduce Chemotherapy-Induced Nausea Researchers have found that olanzapine may be more effective in controlling severe nausea and improving the quality of life in patients with cancer who are undergoing treatment with chemotherapy, according to new findings… September 30 | ASCO News Blog Posts All Blog Posts Targeting Prevention to Reduce the High Human Toll of Rare Cancers At the Rare Cancers Prevention and Interception workshop this year, cancer researchers from across the United States, Canada, and the United Kingdom and from across disciplines sought to address many of the issues that can… Research Highlights: Looking Deep into Genetic Changes that Increase Colorectal Cancer Risk to Prevent or Detect Inherited Cancers Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common inherited genetic change that increases the risk of several kinds of cancer including colorectal cancer. About 3% of all… Defining Patient Tolerability to Cancer Treatments Helps Reduce Negative Outcomes For decades, cancer patients have participated in clinical trials of new therapies, and clinicians have assessed and recorded any adverse or toxic reactions to the treatments. Over the years, researchers have standardized… An Improved Prostate Cancer Biomarker Test May Help Men Avoid Unnecessary Biopsy Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an elevated prostate-specific antigen (PSA) test from those… Meetings and Events Review All Our Meetings and Events Translational Advances in Cancer Prevention Agent Development (TACPAD) – 3rd Biennial Virtual Meeting Date(s): Mon, October 28, 2024: 11:00a.m. ET - Mon, October 28, 2024: 6:00p.m. ET Tue, October 29, 2024: 11:00a.m. ET - Tue, October 29, 2024: 6:00p.m. ET Wed, October 30, 2024: 11:00a.m. ET - Wed, October 30, 2024: 2:30p.m. ET Location: Virtual Symptom Science in the Context of Cancer Caregiving Date(s): Mon, October 28, 2024: 3:00p.m. ET - Mon, October 28, 2024: 4:00p.m. ET Location: Virtual via ZoomGov The Principles and Practice of Cancer Precision Prevention Studies Date(s): Tue, November 12, 2024: 11:00a.m. ET - Tue, November 12, 2024: 12:00p.m. ET Location: Virtual via Webex DCP Updates A timely, informative email with the latest DCP research news, funding announcements and deadlines, training opportunities, and more. Videos and Webinars Cancer prevention videos and webinars related to DCP programs are listed here. Infographics Tap on the desired thumbnail below to view its larger version where you may share the infographic via Twitter and Facebook or download the image by clicking on the appropriate icon: